TOKYO -- About 90% of patients with "obesity disease" in Japan perceive the medical condition as a personal responsibility, ...

Obesity remains a global health crisis, often linked to serious diseases such as diabetes, heart disease, and fatty liver ...

A new medical database automatically compiles the medical records of obese patients and those suffering from obesity-related ...

Obesity affects national economic growth by limiting workforce participation and innovation. An unhealthy workforce results ...

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist designed to treat hyperphagia and obesity. Rhythm is evaluating setmelanotide in a global Phase 3 trial in patients with acquired hypothalamic ...

Obesity prevention strategies often focus on diet, but eating behaviors also play a key role. In a recent study, researchers from Japan investigated factors influencing meal duration, including sex ...

Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering. Across the 68 markets, sales in the obesity market were $12.3 billion in 2021, growing to $206.5 billion ...

A new medical database automatically compiles the medical records of obese patients and those suffering from obesity-related diseases in a uniquely comprehensive and reliable manner. The initiative, ...

Rhythm Pharmaceuticals, Inc. has announced that it received orphan drug designation from Japan's Ministry of Health, Labour and Welfare for setmelanotide, a treatment aimed at acquired ...